All News

A follow up to part one, we learn more about what comes after the third professional year of pharmacy school and beyond

QVAR RediHaler is now commercially available to patients by prescription in 40 mcg and 80 mcg strengths.

A look at the top stories in the world of pharmacy from last week.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Crystalized dolutegravir may be able to reach viral reservoirs and cure HIV.

Pharmacists can play an important role in educating families about poison prevention.

Lorlatinib was designed to bypass non-small cell lung cancer mutations that promote drug resistance

A new tool that can measure cell strength 100 times faster than current methods may optimize drug development for several diseases.

A gene that plays a crucial role in blood cell maturation can mutate and cause cancer to develop.

Top news of the week from Specialty Pharmacy Times.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

The 2017/2018 influenza vaccine was more effective in the United States than Canada and Australia.

Tissue Plasminogen Activator (tPA) is administered in patients with Acute Ischemic Stroke. Becuase tPA administration is time sensitive, caution is required.

Rituximab (Rituxan) sparked remission among patients with pemphigus vulgaris.

The Infectious Diseases Society of America (IDSA) and the Society for Healthcare Epidemiology of America (SHEA) have released updated guidelines for Clostridium difficile infections.

A new study published in the Annals of Internal Medicine this week suggests that opioids may pose a different, unintended untoward consequence in patients: an increased risk of pneumococcal infection.

A popular multiple sclerosis drug may increase the risk of a potentially-fatal brain infection.

A recent report highlights how Americans pay more for prescription drugs compared with other countries.

Less serious adverse events remain a concern for patients treated for chronic diseases.

Ultraviolet C light could be safely harnessed to kill influenza microbes.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

Many pharmacists are turning to credentialing as a way to distinguish themselves professionally.

In addition to myocardial infarction and stroke, migraines may also be linked to an increased risk for venous thromboembolism and atrial fibrillation.

Surgeons may play an integral role in preventing opioid dependency in surgery patients.

Apalutamide (Erleada) was approved based on metastasis-free survival, which is a new clinical endpoint.

Tisagenlecleucel (Kymriah) induced remission in a patient with acute lymphoblastic leukemia who was seemingly out of options.